SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease. [electronic resource]
Producer: 20041018Description: 3556-8 p. digitalISSN:- 0066-4804
- Animals
- Anti-Bacterial Agents -- adverse effects
- Aza Compounds -- adverse effects
- Colony Count, Microbial
- Drug Interactions
- Drug Therapy, Combination
- Female
- Fluoroquinolones
- Liver -- microbiology
- Mefloquine -- adverse effects
- Mice
- Mice, Inbred C57BL
- Moxifloxacin
- Mycobacterium avium-intracellulare Infection -- drug therapy
- Quinolines -- adverse effects
- Spleen -- microbiology
- Thioacetazone -- adverse effects
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.